1 not yet recruiting, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial KSD-101 - Nasopharyngeal Carcinoma (NPC), EBV | Early Phase 1 | Not yet recruiting | Kousai Bio Co., Ltd. | 10 | 2025-01-31 | 2024-12-30 |
| Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Nelfinavir - Non-Hodgkin Lymphoma, Hodgkin Lymphoma | Early Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 | 2014-07-01 | 2016-06-10 |
Castleman Disease (1) · Hodgkin Disease (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Neoplasms (1) · Neoplasms (1) · Sarcoma (1) · Sarcoma, Kaposi (1) · Stomach Neoplasms (1)
Head and Neck Neoplasms (2) · Nasopharyngeal Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Pharyngeal Diseases (2) · Pharyngeal Neoplasms (2) · Stomatognathic Diseases (2) · Carcinoma (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1)
Nelfinavir (1)
Kousai Bio Co., Ltd. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (1)